Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination-Reference-Cited by-同舟云学术

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

van Willigen Wouter W.¹²,Bloemendal Martine¹²,Boers-Sonderen Marye J.²,de Groot Jan Willem B.³,Koornstra Rutger H.T.²⁴,van der Veldt Astrid A.M.⁵⁶,Haanen John B. A. G.⁷,Boudewijns Steve⁸,Schreibelt Gerty¹,Gerritsen Winald R.²,de Vries I. Jolanda M.¹²,Bol Kalijn F.¹²

Affiliation:

1. Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands

2. Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands

3. Department of Medical Oncology, Isala Oncology Center, Zwolle, The Netherlands

4. Department of Internal Medicine, Hospital Rijnstate, Arnhem, The Netherlands

5. Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

6. Department of Radiology & Nuclear Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

7. Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

8. Department of Medical Oncology, Bravis Hospital, Roosendaal, The Netherlands

Funder

The Dutch Cancer Society

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1738814

Reference40 articles.

1. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

2. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

3. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

4. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

5. Pembrolizumab versus Ipilimumab in Advanced Melanoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic Cells in Cancer Immunology and Immunotherapy;Cancers;2024-02-28

2. Dendritic cells as orchestrators of anticancer immunity and immunotherapy;Nature Reviews Clinical Oncology;2024-02-07

3. IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration;International Journal of Molecular Sciences;2023-11-14

4. Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma;Frontiers in Neurology;2023-10-31

5. Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness;Frontiers in Immunology;2023-04-26